SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,450.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 180.00 (4.091%)
Market Cap: £296.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Acquisition

21 Mar 2011 07:00

RNS Number : 2707D
Judges Scientific PLC
21 March 2011
 

JUDGES SCIENTIFIC plc

("Judges Scientific", "Judges" or the "Company")

 

ACQUISITION OF 51% OF DEBEN UK LIMITED

 

Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, announces that it completed on 18 March the acquisition of a 51% indirect interest in Deben UK Limited ("Deben") for a cash consideration of £3.26 million (the "Acquisition").

 

An additional payment will be made to reflect the working capital available at completion in excess of the ongoing requirements of the business. Such payment is expected by Judges to be covered by the cash inherited on completion.

 

The Acquisition has been executed through Bordeaux Acquisition Limited ("BAL"), a 51% owned subsidiary of Judges, which was created for the purpose of effecting the acquisition and which acquired the entirety of Deben's share capital.

 

Financing of the Acquisition

The Acquisition and associated transaction costs are being financed through a £2,422,250 loan provided by Lloyds Bank Corporate Markets to BAL. The loan is split into two parts, both guaranteed by Judges, and comprises an acquisition component of £2.06 million and a property element of £362,250, secured against the freehold property from which Deben operates its business.

 

Equity of £1,013,250 was supplied by the BAL shareholders, pro-rata to their respective interests, predominantly in the form of subordinated loans. Gary and Tracey Edwards, the vendors of Deben, have reinvested £497,000 of their sale proceeds to acquire a 49% shareholding in BAL, while Judges invested £516,250 in respect of its 51% interest.

 

Both parties have entered into a Shareholders' Agreement which includes minority protection provisions and stipulates, inter alia, that BAL has the right of first refusal on potential acquisitions available to the Judges group, provided that such acquisitions meet certain criteria, operate in the field of electron microscopy and can be financed independently by BAL.

 

Information on Deben

Deben designs, manufactures and sells devices used to enable or improve the observation of objects under a microscope. The principal product groups are motor control systems, micro-tensile stages, cooling stages, digital imaging for electron microscopes and beam blanking equipment. The products are sold world-wide to OEM customers (microscope manufacturers that incorporate such equipment in their own instruments) or directly to end users such as universities.

 

The business, established in 1987, is based in Woolpit, Suffolk, and has been managed by Gary Edwards since 1996. It is expected that Mr Edwards, 44, will continue as managing director of Deben for the foreseeable future.

 

Deben's unaudited accounts for the year ended 31 October 2010 show sales of £2 million and pre-tax profits of £862,000. Operating profits, adjusted to eliminate non-recurring items and to reflect Judges Scientific's practices, would have amounted to £707,000. The accounts show net tangible assets of £2.25 million including net cash of £1.36 million. The freehold property was valued on BAL's behalf at £517,500. The price paid for Deben reflects this valuation as well as a multiple of adjusted operating profit.

 

The Board believes that this acquisition is an excellent addition to the Group's electron microscopy business and will be immediately earnings enhancing.

 

Alex Hambro, Chairman of Judges, commented:

"We are delighted to be able to expand our electron microscopy business through the acquisition of Deben. This is a profitable and cash generative business and we expect the transaction, which has not involved the issue of new equity, to be immediately earnings enhancing. We welcome Gary and his team into the Judges group for what we anticipate will be a long and fruitful relationship ".

 

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

 

Pascal Keane, Shore Capital: Tel: 020 7408 4090

 

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

Websites:

 Judges Scientific:www.judges.uk.com

 

Deben: www.deben.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQURSSRAKAOUAR
Date   Source Headline
16th Apr 20257:00 amRNSBoard Change and formation of Executive Committee
8th Apr 202512:35 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSConfirmation of Full Year Results
19th Mar 20257:00 amRNSUnaudited Preliminary Results
6th Mar 20254:08 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSNotice of Investor Presentation
7th Feb 202510:32 amRNSDirector/PDMR Shareholding
3rd Feb 202511:11 amRNSTotal Voting Rights
24th Jan 20256:23 pmRNSDirector/PDMR Shareholding
24th Jan 20253:24 pmRNSHolding(s) in Company
23rd Jan 20257:00 amRNSGrant of Options
20th Jan 20257:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 202511:44 amRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20249:39 amRNSBlocklisting Return
20th Dec 20247:00 amRNSBoard Change
6th Dec 20241:07 pmRNSDirector/PDMR Shareholding
4th Dec 20246:09 pmRNSDirector/PDMR Shareholding
18th Nov 20247:00 amRNSTrading Update
12th Nov 20245:09 pmRNSDirector/PDMR Shareholding
6th Nov 20245:03 pmRNSDirector/PDMR Shareholding
31st Oct 20244:12 pmRNSTotal Voting Rights
18th Oct 20242:20 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
7th Oct 20244:42 pmRNSDirector/PDMR Shareholding
2nd Oct 20249:53 amRNSDirector/PDMR Shareholding
26th Sep 20241:22 pmRNSHolding(s) in Company
26th Sep 202412:31 pmRNSDirector/PDMR Shareholding
25th Sep 20244:59 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSInterim Results
6th Sep 20244:26 pmRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSExecutive Director and Board Appointment
29th Aug 20247:00 amRNSGeotek coring contract
21st Aug 20247:00 amRNSNotice of Investor Presentation
15th Aug 20247:00 amRNSAcquisition of Magsputter Limited
8th Aug 20249:21 amRNSDirector/PDMR Shareholding
30th Jul 20242:45 pmRNSDirector/PDMR Shareholding
29th Jul 20244:53 pmRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20244:54 pmRNSDirector/PDMR Shareholding
3rd Jul 20247:00 amRNSAmendment and Extension of Bank Facilities
28th Jun 20247:00 amRNSAcquisition of Rockwash Geodata Ltd
21st Jun 20244:06 pmRNSBlocklisting Return
7th Jun 20244:42 pmRNSDirector/PDMR Shareholding
6th Jun 20245:18 pmRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
21st May 20245:28 pmRNSResult of AGM and GM
21st May 20247:00 amRNSAGM Statement
10th May 20245:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.